Home > Health > Pharmacy > Drugs and Medications > O > Omalizumab
Anti-IgE monoclonal antibody medication for treating asthma and allergy. Brand name Xolair.
https://www.gene.com/patients/medicines/xolair
Includes fact sheet, prescribing information, and how it's manufactured.
http://www.jacionline.org/article/S0091-6749(07)01781-2/fulltext
Description and analysis of cases of anaphylaxis following omalizumab administration, published in The Journal of Allergy and Clinical Immunology.
https://medlineplus.gov/druginfo/meds/a603031.html
Features information about dosage, usage, warnings, and side effects.
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1681435
Descriptions of allergic asthma and allergic rhinitis pathophysiology and reviews of the pharmacologic, pharmacokinetic, pharmacodynamic, efficacy, and safety data for omalizumab.
http://pages.jh.edu/~gazette/1999/may1099/10sneeze.html
Article about clinical testing of the experimental anti-allergy agent Anti-IgE, in a version called rhuMAb-E25.
http://www.xolair.com/
Information about allergic asthma, how the medication works, and sections for patients, family and friends, and medical professionals.
http://www.xolairpregnancyregistry.com/
Information for patients and health care providers about an observational study of pregnant women in the US taking Xolair.
Home > Health > Pharmacy > Drugs and Medications > O > Omalizumab
Thanks to DMOZ, which built a great web directory for nearly two decades and freely shared it with the web. About us